Regencell Bioscience Holdings (RGC) Stock Overview

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

RGC Stock Information

Symbol

RGC

Address

Chinachem Leighton PlazaCauseway Bay, Hong Kong

Founded

Trading hours

Website

https://www.regencellbioscience.com

Country

🇭🇰 Hong Kong

Phone Number

852 2155 0823

Regencell Bioscience Holdings (RGC) Price Chart

Regencell Bioscience Holdings Overview: Key Details and Summary

Stock data	2023	Change
Price	$6.61	N/A
Market Cap	$86.02M	N/A
Shares Outstanding	13.01M	1.62%
Employees	12.00	N/A
Shareholder Equity	11.99M	-29.81%

Valuation	2023	Change
P/E Ratio	-14.69	N/A
P/B Ratio	7.17	N/A

Growth	2023	Change
Return on Equity	-0.5056	N/A

Earnings	2023	Change
Revenue	$0	N/A
Earnings	-$6.06M	N/A
EPS	-0.45	N/A
Earnings Yield	-0.0681	N/A

Financial Strength	2023	Change
Total Assets	$12.62M	N/A
Total Debt	$463.67K	N/A
Cash on Hand	$11.56M	N/A
Debt to Equity	0.0527	-3.96%
Cash to Debt	$24.94	17.17%
Current Ratio	$19.15	-32.72%